Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0784-2021Class II

TomoTherapy Treatment System -

Accuray Incorporated / initiated 2020-12-10 / Terminated / root cause: software

Accuray Incorporated began a recall of TomoTherapy Treatment System - Product Usage: used as an integrated system for the planning and precise delivery of radiation therapy, stereotactic... on . FDA classified it as Class II and gives the reason as ""MLC tickle error" may result in the delivered dose to effectively rotate from the planned dose". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-0784-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Accuray Incorporated
Product
TomoTherapy Treatment System - Product Usage: used as an integrated system for the planning and precise delivery of radiation therapy, stereotactic radiotherapy, or stereotactic radiosurgery to tumors or other targeted tissues while minimizing the delivery of radiation to vital healthy tissue.
Product code
IYE Accelerator, Linear, Medical
Reason for recall
"MLC tickle error" may result in the delivered dose to effectively rotate from the planned dose.
Root cause tag
software
FDA root cause
Software Design Change
Action
Urgent Medical Device Recall "MLC tickle error" issue during TomoHelical deliver was sent to customers beginning 12/10/2020. Accuray is planning software releases that will address this issue. All TomoTherapy systems at affected software versions will be upgraded to these versions once released.
Quantity in commerce
7 units
Distribution
Worlwide distribution - US Nationwide distribution including in the states of CA, FL, IL, ND, NJ, OK, UT and the countries of Australia, China, Italy, Switzerland, United Arab Emirates.
Product codes and lots
Product Codes: H-0000-0003, 104430, 1018284. System Version 5.1.5. Serial Numbers: 110210, 110319, 110340, 110366, 110383, 110418, 110468

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0784-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0784-2021Class IITerminatedVoluntary: Firm initiated
Z-0785-2021Class IITerminatedVoluntary: Firm initiated